We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.95B
AUM Growth
+$407M
Cap. Flow
+$737M
Cap. Flow %
9.28%
Top 10 Hldgs %
63.45%
Holding
409
New
72
Increased
88
Reduced
65
Closed
155

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$49.7M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$49.3M
3
IMCR icon
Immunocore
IMCR
+$41.4M
4
EXAS
Exact Sciences
EXAS
+$36.8M
5
IMVT icon
Immunovant
IMVT
+$35.1M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$92.8M
2
KO icon
Coca-Cola
KO
+$36M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$31.9M
4
POST icon
Post Holdings
POST
+$26.8M
5
NOMD icon
Nomad Foods
NOMD
+$26.4M

Sector Composition

Rank Sector Weight
1 Healthcare 33.06%
2 Consumer Staples 5.21%
3 Consumer Discretionary 4.94%
4 Technology 3.72%
5 Materials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDP icon
26
Keurig Dr Pepper
KDP
$43B
$49.6M 0.62%
1,486,063
+966,924
+186% +$32.1M
BUD icon
27
AB InBev
BUD
$166B
$48.8M 0.61%
839,000
+137,000
+20% +$8.39M
NARI
28
DELISTED
Inari Medical, Inc. Common Stock
NARI
$48.6M 0.61%
1,009,252
+786,501
+353% +$34.9M
BHVN icon
29
Biohaven
BHVN
$2.08B
$48.5M 0.61%
1,396,968
+597,705
+75% +$23.6M
KURA icon
30
Kura Oncology
KURA
$826M
$48.4M 0.61%
2,350,000
+302,000
+15% +$6.21M
CPB icon
31
Campbell Soup
CPB
$6.58B
$48.3M 0.61%
1,067,914
+517,550
+94% +$23.1M
MDGL icon
32
Madrigal Pharmaceuticals
MDGL
$11.4B
$42M 0.53%
150,000
-18,000
-11% -$4.28M
VYGR icon
33
Voyager Therapeutics
VYGR
$189M
$41.1M 0.52%
5,200,000
+528,000
+11% +$4.43M
BCYC
34
Bicycle Therapeutics
BCYC
$280M
$39.9M 0.5%
1,972,000
+300,000
+18% +$6.78M
HUM icon
35
Humana
HUM
$44B
$38.7M 0.49%
103,694
-21,490
-17% -$7.26M
SPB icon
36
Spectrum Brands
SPB
$2.04B
$37.8M 0.48%
439,377
+247,809
+129% +$21.5M
TMCI icon
37
Treace Medical Concepts
TMCI
$284M
$35.6M 0.45%
5,360,000
+2,960,000
+123% +$23.9M
TOST icon
38
Toast
TOST
$19.1B
$35.1M 0.44%
1,362,569
+427,882
+46% +$10.3M
SMPL icon
39
Simply Good Foods
SMPL
$918M
$34.6M 0.44%
+957,163
New +$34.2M
DYN icon
40
Dyne Therapeutics
DYN
$4.8B
$34.3M 0.43%
970,891
-29,109
-3% -$846K
WDAY icon
41
Workday
WDAY
$39B
$33.6M 0.42%
150,476
+109,164
+264% +$26.3M
IMCR icon
42
Immunocore
IMCR
$1.72B
$33.1M 0.42%
976,000
+812,000
+495% +$41.4M
PRTA icon
43
Prothena Corp
PRTA
$440M
$32.2M 0.41%
1,560,000
+464,000
+42% +$10M
DOCU
44
DocuSign
DOCU
$10.4B
$32M 0.4%
597,921
-205,754
-26% -$11.6M
FIVN icon
45
FIVE9
FIVN
$2.12B
$31.9M 0.4%
722,582
+261,476
+57% +$13.6M
ISRG icon
46
Intuitive Surgical
ISRG
$126B
$31.7M 0.4%
71,227
+28,250
+66% +$11.3M
TMO icon
47
Thermo Fisher Scientific
TMO
$214B
$31.1M 0.39%
56,158
+41,182
+275% +$23.6M
NVRO
48
DELISTED
NEVRO CORP.
NVRO
$30.9M 0.39%
3,672,000
+48,000
+1% +$512K
SAM icon
49
Boston Beer
SAM
$1.93B
$29.7M 0.37%
97,292
+1,093
+1% +$313K
SBUX icon
50
Starbucks
SBUX
$121B
$29.1M 0.37%
373,250
-96,820
-21% -$7.89M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Armistice Capital held 409 positions worth $7.95B, up 5.4% from $7.54B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Armistice Capital deployed $737M of net new capital in Q2 2024, opening 72 new positions and adding to 88 existing holdings. Its largest new stake was Simply Good Foods: 957,163 shares worth $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Coca-Cola, an estimated $36M trimmed.

  • Armistice Capital's largest Q2 2024 buy was Simply Good Foods: 957,163 shares worth $34.6M.
  • Armistice Capital added most to Alkermes in Q2 2024, an estimated $49.7M increase.
  • Armistice Capital's biggest Q2 2024 reduction was Coca-Cola, cutting an estimated $36M.
  • Armistice Capital fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2024, selling an estimated $92.8M.
  • Armistice Capital's ten largest holdings make up 63% of its $7.95B portfolio in Q2 2024.
  • Armistice Capital opened 72 new positions and closed 155 in Q2 2024.
  • Armistice Capital's portfolio value rose 5.4% quarter-over-quarter to $7.95B.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.